Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Insurance, Life”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,621 records · Page 90Linked to original sources

Ontario Securities Commission has authority to investigate viatical settlement purchase program.

On 27 October 2003, the Ontario Superior Court of Justice held that the Ontario Securities Commission (the Commission) has the authority to compel testimony and the production of written documents from parties that are not registered under the Ontario Securities Act (OSA). The finding in Universal Settlements International, Inc v Ontario (Securities Commission) is important because it affirms the authority of the Commission to investigate businesses that might be engaging in the sale of illegal viatical settlements, an unregulated industry with potential negative impacts for people living with HIV/AIDS.

HIV Infections↗

Mortality in gastric cancer patients treated with gastrectomy.

Two clinical series that assessed outcome of gastric cancer treated with gastrectomy and extended lymphadenectomy were reviewed using standard insurance medicine mortality abstract methods. The results were not conclusive; although they did suggest that extended level 2 (D2) lymphadenectomy may produce better long-term mortality outcomes than less extensive surgery in some circumstances.

Actuarial Analysis↗

Cystic fibrosis--a genetic dilemma.

Cystic fibrosis is a common genetic disease that usually presents in early childhood as a devastating disease affecting pulmonary function and at times gastrointestinal functioning and nutritional status. Variant forms of this disease have been described, which may have a delayed age of onset or a milder clinical course. Numerous genetic mutations have been described in cystic fibrosis. There are several mutations that are known to be associated with late onset disease or mild clinical disease. Research continues into these genetic mutations and various modifiers that may help to more accurately predict the final phenotypic presentation.

Actuarial Analysis↗

Barrett's esophagus.

Barrett's esophagus is a premalignant condition associated with gastroesophageal reflux disease. This review will discuss the diagnosis, etiology and treatment of this common disorder.

Adenocarcinoma↗

Differentiating age-related memory loss from early dementia.

Memory loss occurs in more than 40% of individuals older than age 60. Alzheimer's disease (AD) or another type of dementia develops in some of these people, but others remain healthy. There is currently no reliable way to distinguish between these 2 outcomes.

Age Distribution↗

Autoimmune hepatitis.

Autoimmune hepatitis is an uncommon disease causing chronic inflammation of the liver and associated with various circulating autoantibodies. It shares some characteristics with other autoimmune liver diseases, such as primary biliary cirrhosis and sclerosing cholangitis. There has been confusion in past years regarding this entity, but there are now recognized diagnostic criteria by which to make a proper diagnosis. The disease is usually treatable with steroids. Certain proportions of treated patients become cured, although relapse is a problem often requiring chronic administration of steroid therapy. The expected mortality is close to normal in individuals who are cured or have only mild disease.

Biopsy↗

Coronary angiography report.

Reports of coronary angiography frequently determine underwriting decisions. This report exemplifies the ideal format and content for effective clinical or insurance risk assessment.

Angioplasty↗